Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Sexual Risk Among African American Women: Psychological Factors and the Mediating Role of Social Skills.

Curran TM, Monahan JL, Samp JA, Coles VB, DiClemente RJ, Sales J.

Commun Q. 2016;64(5):536-552. doi: 10.1080/01463373.2015.1132241. Epub 2016 Mar 24.

2.

Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.

Spinelli SL, Lannan KL, Casey AE, Croasdell A, Curran TM, Henrichs KF, Pollock SJ, Milne GA, Refaai MA, Francis CW, Phipps RP, Blumberg N.

Transfusion. 2014 Jun;54(6):1569-79. doi: 10.1111/trf.12485. Epub 2013 Nov 5.

3.

The sensitivity of the Bayesian HPD method to the choice of prior.

Triggs CM, Curran TM.

Sci Justice. 2006 Jul-Sep;46(3):169-78.

PMID:
17388244
4.

Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis.

Lim MJ, Beake J, Bible E, Curran TM, Ramirez-Montealegre D, Pearce DA, Cooper JD.

Neuropathol Appl Neurobiol. 2006 Oct;32(5):469-82.

PMID:
16972881
5.

Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Ramirez-Montealegre D, Chattopadhyay S, Curran TM, Wasserfall C, Pritchard L, Schatz D, Petitto J, Hopkins D, She JX, Rothberg PG, Atkinson M, Pearce DA.

Neurology. 2005 Feb 22;64(4):743-5.

PMID:
15728308
6.

Altered gene expression in the eye of a mouse model for batten disease.

Chattopadhyay S, Kingsley E, Serour A, Curran TM, Brooks AI, Pearce DA.

Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2893-905.

PMID:
15326100
7.

Altered amino acid levels in sera of a mouse model for juvenile neuronal ceroid lipofuscinoses.

Pearce DA, McCall K, Mooney RA, Chattopadhyay S, Curran TM.

Clin Chim Acta. 2003 Jun;332(1-2):145-8. No abstract available.

PMID:
12763292
8.

Early changes in gene expression in two models of Batten disease.

Elshatory Y, Brooks AI, Chattopadhyay S, Curran TM, Gupta P, Ramalingam V, Hofmann SL, Pearce DA.

FEBS Lett. 2003 Mar 13;538(1-3):207-12.

9.

An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA.

Hum Mol Genet. 2002 Jun 1;11(12):1421-31.

PMID:
12023984
10.

Membrane locus and pH sensitivity of paraben inhibition of alkali production by oral streptococci.

Ma Y, Rutherford GC, Curran TM, Reidmiller JS, Marquis RE.

Oral Microbiol Immunol. 1999 Aug;14(4):244-9.

PMID:
10551169
11.

Turning on and turning off the arginine deiminase system in oral streptococci.

Curran TM, Ma Y, Rutherford GC, Marquis RE.

Can J Microbiol. 1998 Nov;44(11):1078-85.

PMID:
10030002
12.
13.

Arginine deiminase system and acid adaptation of oral streptococci.

Curran TM, Lieou J, Marquis RE.

Appl Environ Microbiol. 1995 Dec;61(12):4494-6.

14.

Inhibition of streptococcal growth, F-ATPase and pyrophosphatase by diphosphonates.

Hsu MT, Sturr G, Curran TM, Marquis RE.

Oral Microbiol Immunol. 1995 Feb;10(1):47-53.

PMID:
7644273
15.

Quasi-irreversible inhibition of enolase of Streptococcus mutans by fluoride.

Curran TM, Buckley DH, Marquis RE.

FEMS Microbiol Lett. 1994 Jun 15;119(3):283-8.

PMID:
8050711
17.

Cholesterol pleural effusion.

CURRAN TM.

Edinb Med J. 1948 Apr;55(4):252-5. No abstract available.

Supplemental Content

Loading ...
Support Center